SPONSOR
Weill Medical College of Cornell University
Total Trials
17
Recruiting
17
Phases
Phase 2, Phase 4, Phase 1, EARLY_Phase 1, Phase 1, Phase 2
Conditions studied: Advanced CancerGriefTraumaPsychotherapyCritical CareEsophageal AdenocarcinomaGastric AdenocarcinomaGastroesophageal Junction AdenocarcinomaCOVID-19 PneumoniaCOVID-19
Weill Medical College of Cornell University is a clinical research sponsor with 17 registered studies on ClinicalTrials.gov, of which 17 are actively recruiting participants. Research covers conditions including Advanced Cancer, Grief, Trauma, Psychotherapy.
The trial portfolio spans Phase 2, Phase 4, Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Weill Medical College of Cornell University
How many clinical trials has Weill Medical College of Cornell University sponsored?
ClinicalMetric currently tracks 17 clinical trials sponsored by Weill Medical College of Cornell University, of which 17 are actively recruiting participants. These trials cover conditions including Advanced Cancer, Grief, Trauma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Weill Medical College of Cornell University research focus on?
Weill Medical College of Cornell University clinical trials span Advanced Cancer, Grief, Trauma, Psychotherapy, Critical Care, and additional conditions. The research pipeline includes Phase 2, Phase 4, Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Weill Medical College of Cornell University clinical trial?
To participate in a Weill Medical College of Cornell University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Weill Medical College of Cornell University trials with current recruitment status updated daily.
Clinical Trials by Weill Medical College of Cornell University
NCT06811376
Recruiting
Pilot Trial of Spiritual Care Interventions for Patients With Cancer
Advanced Cancer
NCT05587517 Phase 2
Recruiting
A Clinical Trial of Interventions to Support Family Surrogates of Critically Ill Patients
Grief
NCT06340711 Phase 2
Recruiting
Study of Suratadenoturev (OBP-301) in Combination With Pembrolizumab in Esophagogastric Adenocarcinoma
Esophageal Adenocarcinoma
NCT05164744
Recruiting
Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors
COVID-19 Pneumonia
NCT04563507 Phase 2
Recruiting
Combined Immunotherapies in Metastatic ER+ Breast Cancer
Breast Cancer
NCT06623656 Phase 2
Recruiting
Preoperative Radioimmunotherapy Versus Chemoimmunotherapy in NSCLC
Carcinoma, Non-Small-Cell Lung
NCT04982757
Recruiting
Accelerated TMS for Depression and OCD
Depression
NCT07046429
Recruiting
Affect of Melatonin on Sleep and Cognition in Cirrhosis
Hepatic Encephalopathy
NCT04679012 Phase 2
Recruiting
Polatuzumab Vedotin in Combination With Chemotherapy in Subjects With Richter's Transformation
Richter Syndrome
NCT03217006
Recruiting
Randomization of Single vs Multiple Arterial Grafts
Coronary Artery Disease
NCT06377371 Phase 4
Recruiting
Feasibility of Intraoperative Tracing of Meningioma Using [Cu64]DOTATATE
Meningioma
NCT05743621 Phase 1
Recruiting
Study of TVB-2640 in Men With Metastatic Castration-Resistant Prostate Cancer
Prostatic Neoplasms, Castration-Resistant
NCT03804944 Phase 2
Recruiting
Converting HR+ Breast Cancer Into an Individualized Vaccine
Breast Cancer
NCT04887116 EARLY_Phase 1
Recruiting
Piloting Virtual Reality Environments to Treat PTSD in Healthcare Workers
Posttraumatic Stress Disorder
NCT04946370 Phase 1, Phase 2
Recruiting
Phase I/II Trial of Pembrolizumab and Androgen-receptor Inhibitor With or Without 225Ac-J591 for Progressive Metastatic Castration Resistant Prostate Cancer
Prostate Cancer
NCT07257484 Phase 4
Recruiting
Tirzepatide's Role in Postmenopausal HR+ Breast Cancer Survivors
Obesity (Disorder)
NCT05302271 Phase 1
Recruiting
Phase IA and IB Study of AAVrh.10hFXN Gene Therapy for the Cardiomyopathy of Friedreich's Ataxia
Friedreich Ataxia
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology